Market Movers

Teleflex Incorporated’s Stock Price Soars to $218.07, Marking a Robust Increase of 2.99%

Teleflex Incorporated (TFX)

218.07 USD +6.34 (+2.99%) Volume: 0.45M

Teleflex Incorporated’s stock price stands at 218.07 USD, witnessing an impressive surge of +2.99% in this trading session, although it bears a YTD loss of -12.54%. Trading volume for TFX remains robust at 0.45M, indicating sustained investor interest.


Latest developments on Teleflex Incorporated

Teleflex Inc. (NYSE:TFX) has experienced various stock price movements recently due to a series of key events. Sumitomo Mitsui Trust Holdings Inc. trimmed its stake in the company, while Tokio Marine Asset Management Co. Ltd. boosted its holdings. Additionally, State of Alaska Department of Revenue and Commonwealth Equity Services LLC sold shares of Teleflex. Despite these changes, Investing.com maintains its rating on the stock, citing potential gains and even raising the price target. First Trust Direct Indexing L.P. also showed confidence in the company by purchasing shares. These developments indicate a mix of buying and selling activity surrounding Teleflex, making it a stock to watch in the current market.


Teleflex Incorporated on Smartkarma

Analysts at Baptista Research have provided positive coverage of Teleflex Inc on Smartkarma. In their report titled “Teleflex Incorporated: Driving Durable Growth through Organic Growth Opportunities and Innovation! – Major Drivers”, analysts highlighted the promising Q1 2024 earnings results of the company. Led by Liam Kelly, the Chairman, President, and CEO, along with Thomas Powell, the EVP and CFO, Teleflex achieved revenues of $737.8 million, a 3.8% YoY increase. The utilization of the company’s products trended positively, meeting expectations.

Furthermore, Baptista Research‘s report “Teleflex Incorporated: M&A Focus & 5 Other Strategies Driving Growth! – Financial Forecasts” emphasized the decent performance of Teleflex Inc in the fourth quarter of 2023. With a 2.1% YoY revenue growth, the company demonstrated financial robustness. The analysts also noted a stable-to-improving environment for material inflation and supply chains, with expectations of continued improvements throughout 2024.


A look at Teleflex Incorporated Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience2
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Teleflex Inc, a global provider of medical technology products, has received a positive outlook based on Smartkarma Smart Scores. With a high Value score of 4 and Momentum score of 4, the company is positioned well for long-term growth and stability. While the Dividend and Growth scores are average at 3, Teleflex’s focus on resilience with a score of 2 indicates potential challenges in the future. Overall, the company’s strong performance in value and momentum bodes well for its future prospects in the medical technology industry.

Teleflex Incorporated, known for developing, manufacturing, and supplying single-use medical devices, has been rated favorably by Smartkarma Smart Scores. With a solid Value score of 4 and a respectable Momentum score of 4, the company shows promise for sustained success. Although the Dividend and Growth scores are average at 3, Teleflex’s lower Resilience score of 2 suggests the need for caution. In summary, Teleflex Inc‘s strong value and momentum ratings indicate a positive long-term outlook in the competitive medical technology market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars